Sender Co & Partners Inc. Grows Stock Holdings in Kenvue Inc. $KVUE

Sender Co & Partners Inc. grew its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 7.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 114,680 shares of the company’s stock after purchasing an additional 8,378 shares during the period. Kenvue makes up approximately 1.4% of Sender Co & Partners Inc.’s holdings, making the stock its 20th largest position. Sender Co & Partners Inc.’s holdings in Kenvue were worth $2,750,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in KVUE. Starboard Value LP bought a new stake in shares of Kenvue during the fourth quarter valued at approximately $467,864,000. Vanguard Group Inc. increased its position in shares of Kenvue by 4.9% during the first quarter. Vanguard Group Inc. now owns 229,144,387 shares of the company’s stock valued at $5,494,882,000 after acquiring an additional 10,600,682 shares in the last quarter. Third Point LLC bought a new stake in shares of Kenvue during the first quarter valued at approximately $213,422,000. Maverick Capital Ltd. bought a new stake in shares of Kenvue during the first quarter valued at approximately $203,036,000. Finally, Nuveen LLC bought a new stake in shares of Kenvue during the first quarter valued at approximately $187,123,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on KVUE. Bank of America reduced their price target on shares of Kenvue from $27.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, July 15th. Citigroup reduced their price target on shares of Kenvue from $24.50 to $22.00 and set a “neutral” rating for the company in a research report on Tuesday, July 15th. Canaccord Genuity Group reduced their price target on shares of Kenvue from $29.00 to $26.00 and set a “buy” rating for the company in a research report on Friday, August 8th. JPMorgan Chase & Co. cut their target price on shares of Kenvue from $27.00 to $26.00 and set an “overweight” rating for the company in a research report on Friday, July 25th. Finally, Royal Bank Of Canada cut their target price on shares of Kenvue from $24.00 to $22.00 and set a “sector perform” rating for the company in a research report on Friday, August 8th. Five investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Kenvue presently has a consensus rating of “Hold” and an average price target of $24.38.

Kenvue Trading Down 9.3%

Shares of KVUE stock opened at $18.64 on Friday. Kenvue Inc. has a 1 year low of $17.15 and a 1 year high of $25.17. The firm has a fifty day moving average price of $21.37 and a 200-day moving average price of $22.38. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The company has a market cap of $35.76 billion, a price-to-earnings ratio of 25.18, a PEG ratio of 2.67 and a beta of 0.83.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The firm had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the firm posted $0.32 EPS. The company’s revenue for the quarter was down 4.0% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were issued a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a yield of 4.5%. This is an increase from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s payout ratio is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.